1832 Asset Management
CVS icon

1832 Asset Management’s CVS Health CVS Stock Holding History

1832 Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.66M Sell
37,070
-391
-1% -$30.1K ﹤0.01% 488
2025
Q4 		$2.97M Buy
+37,461
New +$2.95M ﹤0.01% 484
2025
Q2 		– Sell
-21,769
Closed -$1.47M – 685
2025
Q1 		$1.47M Sell
21,769
-11,955
-35% -$715K ﹤0.01% 527
2024
Q4 		$1.51M Sell
33,724
-3,589
-10% -$201K ﹤0.01% 535
2024
Q3 		$2.35M Buy
+37,313
New +$2.18M ﹤0.01% 502
2024
Q2 		– Sell
-27,126
Closed -$2.16M – 906
2024
Q1 		$2.16M Sell
27,126
-4,872
-15% -$372K ﹤0.01% 483
2023
Q4 		$2.53M Buy
31,998
+7,762
+32% +$552K ﹤0.01% 447
2023
Q3 		$1.69M Sell
24,236
-1,726
-7% -$122K ﹤0.01% 512
2023
Q2 		$1.79M Sell
25,962
-36,783
-59% -$2.62M ﹤0.01% 512
2023
Q1 		$4.66M Buy
62,745
+44,016
+235% +$3.69M 0.01% 410
2022
Q4 		$1.75M Sell
18,729
-3,136
-14% -$303K ﹤0.01% 554
2022
Q3 		$2.08M Sell
21,865
-19,072
-47% -$1.89M ﹤0.01% 504
2022
Q2 		$3.79M Sell
40,937
-14,590
-26% -$1.42M 0.01% 444
2022
Q1 		$5.56M Sell
55,527
-123,726
-69% -$13M 0.01% 439
2021
Q4 		$18.5M Sell
179,253
-120,635
-40% -$11.1M 0.03% 252
2021
Q3 		$25.7M Sell
299,888
-67,628
-18% -$5.66M 0.05% 236
2021
Q2 		$30.5M Sell
367,516
-116,759
-24% -$9.56M 0.06% 217
2021
Q1 		$36.8M Buy
484,275
+61,340
+15% +$4.47M 0.08% 196
2020
Q4 		$28.6M Buy
422,935
+358,165
+553% +$23.3M 0.07% 208
2020
Q3 		$3.75M Sell
64,770
-125
-0.2% -$7.78K 0.01% 355
2020
Q2 		$4.21M Buy
64,895
+15,815
+32% +$996K 0.01% 315
2020
Q1 		$2.95M Buy
49,080
+4,620
+10% +$308K 0.01% 353
2019
Q4 		$3.29M Buy
44,460
+43,256
+3,593% +$3.04M 0.01% 335
2019
Q3 		$76K Sell
1,204
-17,850
-94% -$1.06M ﹤0.01% 552
2019
Q2 		$1.04M Sell
19,054
-71,726
-79% -$3.86M ﹤0.01% 458
2019
Q1 		$4.87M Buy
90,780
+89,700
+8,306% +$5.54M 0.02% 283
2018
Q4 		$71K Sell
1,080
-586
-35% -$43.7K ﹤0.01% 476
2018
Q3 		$131K Buy
1,666
+318
+24% +$22.7K ﹤0.01% 515
2018
Q2 		$91K Sell
1,348
-123,457
-99% -$8.14M ﹤0.01% 489
2018
Q1 		$7.8M Buy
124,805
+86,102
+222% +$6.18M 0.03% 244
2017
Q4 		$2.73M Buy
38,703
+2,898
+8% +$211K 0.01% 346
2017
Q3 		$2.89M Sell
35,805
-338,702
-90% -$26.8M 0.01% 331
2017
Q2 		$30.1M Sell
374,507
-126,709
-25% -$10M 0.14% 154
2017
Q1 		$39.3M Sell
501,216
-6,277,961
-93% -$501M 0.14% 143
2016
Q4 		$573M Buy
6,779,177
+2,876,590
+74% +$233M 0.97% 27
2016
Q3 		$347M Buy
3,902,587
+131,925
+3% +$12.5M 1.3% 17
2016
Q2 		$363M Buy
3,770,662
+32,130
+0.9% +$3.2M 1.41% 16
2016
Q1 		$650M Buy
3,738,532
+17,577
+0.5% +$1.71M 1.58% 12
2015
Q4 		$368M Buy
3,720,955
+165,300
+5% +$16.2M 1.59% 11
2015
Q3 		$344M Buy
3,555,655
+1,414,897
+66% +$149M 1.44% 15
2015
Q2 		$224M Buy
2,140,758
+1,097,193
+105% +$112M 0.76% 37
2015
Q1 		$108M Sell
1,043,565
-704,053
-40% -$71.2M 0.41% 69
2014
Q4 		$168M Buy
1,747,618
+239,255
+16% +$21.1M 0.52% 46
2014
Q3 		$120M Buy
1,508,363
+7,963
+0.5% +$628K 0.39% 67
2014
Q2 		$113M Sell
1,500,400
-1,440,482
-49% -$109M 0.36% 73
2014
Q1 		$218M Buy
2,940,882
+1,926,914
+190% +$136M 0.75% 38
2013
Q4 		$72.6M Buy
+1,013,968
New +$65.1M 0.28% 92
2013
Q3 		– Sell
-179,175
Closed -$10.2M – 387
2013
Q2 		$10.2M Buy
+179,175
New +$10.4M 0.04% 228

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

1832 Asset Management's CVS Position: Q1 2026 in Review

1832 Asset Management reduced its CVS Health (CVS) stake by 1% in Q1 2026, selling an estimated $30.1K and leaving 37,070 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #488.

1832 Asset Management first reported a position in CVS in Q2 2013 and has held it in 48 quarters since. The position peaked at $650M in Q1 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • 1832 Asset Management held 37,070 shares of CVS Health worth $2.66M as of Q1 2026.
  • 1832 Asset Management sold 391 CVS Health shares in Q1 2026, an estimated $30.1K.
  • CVS Health made up ﹤0.01% of 1832 Asset Management's portfolio in Q1 2026, its #488 holding.
  • 1832 Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 48 quarters since.
  • 1832 Asset Management's CVS Health position peaked at $650M in Q1 2016.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.